![](/img/cover-not-exists.png)
Severe neutropenia during cabazitaxel treatment is associated with survival benefit in men with metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of the TROPIC phase III trial
Meisel, Alexander, von Felten, Stefanie, Vogt, Deborah R., Liewen, Heike, de Wit, Ronald, de Bono, Johann, Sartor, Oliver, Stenner-Liewen, FrankVolume:
56
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2015.12.009
Date:
March, 2016
File:
PDF, 748 KB
english, 2016